You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

TUSSIONEX PENNKINETIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tussionex Pennkinetic patents expire, and when can generic versions of Tussionex Pennkinetic launch?

Tussionex Pennkinetic is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in TUSSIONEX PENNKINETIC is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.

Paragraph IV (Patent) Challenges for TUSSIONEX PENNKINETIC
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TUSSIONEX PENNKINETIC Extended-release Capsules chlorpheniramine polistirex; hydrocodone polistirex 8 mg/10 mg and 4 mg/5 mg 019111 1 2004-09-10

US Patents and Regulatory Information for TUSSIONEX PENNKINETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TUSSIONEX PENNKINETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TUSSIONEX PENNKINETIC

See the table below for patents covering TUSSIONEX PENNKINETIC around the world.

Country Patent Number Title Estimated Expiration
South Korea 910003557 ⤷  Try a Trial
New Zealand 208155 PROLONGED-RELEASE LIQUID PHARMACEUTICAL COMPOSITIONS CONTAINING SUSPENSION OF COATED DRUG-RESIN COMPLEX ⤷  Try a Trial
Denmark 164019 ⤷  Try a Trial
Mexico 171030 FORMULACIONES FARMACEUTICAS DE LIBERACION PROLONGADA, LIQUIDAS, QUE CONTIENEN CONSTITUYENTES IONICOS ⤷  Try a Trial
Australia 565487 ⤷  Try a Trial
Australia 2789184 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.